PubRank

C Paoletti

Author PubWeight™ 109.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization. J Mol Biol 1967 10.36
2 A new fluorometric method for RNA and DNA determination. Anal Biochem 1966 6.74
3 cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA. J Virol 1990 3.40
4 Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991 2.79
5 Characterization of a new class of circular DNA molecules in yeast. Biochem Biophys Res Commun 1971 2.33
6 alpha-DNA II. Synthesis of unnatural alpha-anomeric oligodeoxyribonucleotides containing the four usual bases and study of their substrate activities for nucleases. Nucleic Acids Res 1987 2.06
7 Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988 1.91
8 Control of UV induction of recA protein. Proc Natl Acad Sci U S A 1983 1.68
9 An analytical study of the dimerization of in vitro generated RNA of Moloney murine leukemia virus MoMuLV. Nucleic Acids Res 1990 1.62
10 Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 1988 1.57
11 alpha-DNA. VI: Comparative study of alpha- and beta-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition. Nucleic Acids Res 1987 1.53
12 [Electrochemotherapy, a new antitumor treatment: first clinical trial]. C R Acad Sci III 1991 1.52
13 Preparation and properties of nuclear and satellite deoxyribonucleic acid of Trypanosoma cruzi. J Mol Biol 1967 1.31
14 Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 1991 1.26
15 The use of ethidium bromide-circular DNA complexes for the fluorometric analysis of breakage and joining of DNA. J Mol Biol 1971 1.23
16 Smoking cessation rates 4 years after treatment by nicotine gum and acupuncture. Prev Med 1997 1.22
17 Purification and characterization of recA protein from salmonella typhimurium. J Biol Chem 1983 1.20
18 A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs. Proc Natl Acad Sci U S A 1974 1.18
19 [Interaction of ethidium hydrobromate (EH) with polyribonucleotides. Applications to the study of hybridization reactions]. C R Acad Sci Hebd Seances Acad Sci D 1965 1.15
20 Initial degradation of deoxyribonucleic acid after injection in mammals. Cancer Res 1965 1.06
21 Comparative activity of alpha- and beta-anomeric oligonucleotides on rabbit beta globin synthesis: inhibitory effect of cap targeted alpha-oligonucleotides. Biochem Biophys Res Commun 1989 1.05
22 A protein inhibitor of acid deoxyribonucleases. Proc Natl Acad Sci U S A 1969 1.03
23 VanA-type enterococci from humans, animals, and food: species distribution, population structure, Tn1546 typing and location, and virulence determinants. Appl Environ Microbiol 2007 1.03
24 [Fractionation and characterization of desoxyribonucleic acid (DNA) of trypanosomes (Trypanosoma equiperdum)]. C R Acad Sci Hebd Seances Acad Sci D 1966 1.00
25 Alpha-DNA VIII: thermodynamic parameters of complexes formed between the oligo-alpha-deoxynucleotides: alpha-d(GGAAGG) and alpha-d(CCTTCC) and their complementary oligo-beta-deoxynucleotides: beta-d(CCTTCC) and beta-d(GGAAGG) are different. Nucleic Acids Res 1989 0.96
26 Alpha-DNA. IV: Alpha-anomeric and beta-anomeric tetrathymidylates covalently linked to intercalating oxazolopyridocarbazole. Synthesis, physicochemical properties and poly (rA) binding. Nucleic Acids Res 1987 0.96
27 Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137). Recent Results Cancer Res 1980 0.94
28 Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives. J Med Chem 1984 0.93
29 Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative. Nucleic Acids Res 1991 0.92
30 Circulating tumour cells: insights into tumour heterogeneity. J Intern Med 2013 0.91
31 Ellipticine and derivatives induce breakage of L1210 cells DNA in vitro. Biochem Pharmacol 1979 0.91
32 An immunoradiometric quantitative assay of Escherichia coli recA protein. Biochimie 1982 0.91
33 Relative efficiencies of a series of square-planar plantinum(II) compounds on Salmonella mutagenesis. Mutat Res 1977 0.90
34 Lack of single-strand DNA-binding protein amplification under conditions of SOS induction in E. coli. Mol Gen Genet 1983 0.90
35 Voltage-dependent introduction of a d[alpha]octothymidylate into electropermeabilized cells. Biochem Biophys Res Commun 1989 0.88
36 Circular oligomers in mitochondrial DNA of human and beef nonmalignant thyroid glands. Proc Natl Acad Sci U S A 1972 0.88
37 Synthesis, thermal stability and reactivity towards 9-aminoellipticine of double-stranded oligonucleotides containing a true abasic site. Nucleic Acids Res 1989 0.87
38 [N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)]. Nouv Presse Med 1981 0.87
39 Alpha-anomeric DNA: beta-RNA hybrids as new synthetic inhibitors of Escherichia coli RNase H, Drosophila embryo RNase H and M-MLV reverse transcriptase. Gene 1988 0.87
40 [Kinetic study of the replicative forms of DNA in animal cells]. Biochim Biophys Acta 1967 0.87
41 A new DNA intercalating drug: Methoxy-9-ellipticine. FEBS Lett 1971 0.86
42 Frameshift lesions induced by oxazolopyridocarbazoles are recognized by the mismatch repair system in Escherichia coli. Mutat Res 1988 0.85
43 A yeast mitochondrial deoxyribonuclease stimulated by ethidium bromide. Biochem Biophys Res Commun 1972 0.85
44 [Isolation and fractionation of yeast deoxyribonucleic acid (DNA)]. C R Acad Sci Hebd Seances Acad Sci D 1966 0.85
45 Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system. J Med Chem 1981 0.85
46 [Purification and properties of a snail (Helix pomatia L.) hepato-pancreas acid desoxyribonuclease]. C R Acad Sci Hebd Seances Acad Sci D 1966 0.85
47 Efficient breakage of DNA apurinic sites by the indoleamine related 9-amino-ellipticine. Chem Biol Interact 1986 0.84
48 [Mitochondrial DNA of malignant cells]. Bull Cancer 1971 0.84
49 Different levels of induction of RecA protein in E. coli (PQ 10) after treatment with two related carcinogens. Nucleic Acids Res 1983 0.84
50 A randomised 2 x 2 factorial design to evaluate different smoking cessation methods. Rev Epidemiol Sante Publique 1992 0.84
51 Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship. Mol Pharmacol 1992 0.84
52 Interactions between ellipticine and some derivatives and phospholipids in model membranes. FEBS Lett 1979 0.84
53 Quantification by fluorescence of apurinic sites in DNA. Biochem Biophys Res Commun 1987 0.83
54 Measurement of recA protein induction in Salmonella typhimurium: a possible biochemical test for the detection of DNA damaging agents. Biochimie 1983 0.83
55 alpha-DNA X: alpha and beta tetrathymidilates covalently linked to oxazolopyridocarbazolium (OPC): comparative stabilization of oligo beta-[dT]:oligo beta-[dA] and oligo alpha-[dT]:oligo beta-[dA] duplexes by the intercalating agent. Nucleic Acids Res 1989 0.82
56 Lipid peroxidation in liver: hydroxy dimethyl carbazole a new potent inhibitor. Biochem Biophys Res Commun 1980 0.82
57 [A new antitumor compound: hydroxy-9 ellipticin. Effect on mouse L 1210 leukemia]. C R Acad Sci Hebd Seances Acad Sci D 1973 0.82
58 Inhibition of Moloney murine leukemia virus reverse transcriptase by alpha-anomeric oligonucleotides. Biochem Biophys Res Commun 1989 0.82
59 Does cruciform DNA provide a recognition signal for DNA-topoisomerase II? Biochimie 1992 0.81
60 Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study. Br J Cancer 2007 0.81
61 Mitochondrial and nuclear mutagenicity of ellipticine and derivatives in the yeast Saccharomyces cerevisiae. Biochem Pharmacol 1982 0.80
62 [Studies on the toxicity of 9-hydroxyellipticine]. C R Acad Sci Hebd Seances Acad Sci D 1974 0.80
63 [Studies on the interaction of a diamine steroid, irehdiamine A, with desoxyribonucleic acid]. C R Acad Sci Hebd Seances Acad Sci D 1968 0.80
64 Mechanism of deoxyribonucleic acid degradation by an acid deoxyribonuclease from the snail Helix aspersa Müll. Biochemistry 1972 0.80
65 [Potentiation of the antitumoral effect of electrochemotherapy by immunotherapy with allogeneic cells producing interleukin 2]. C R Acad Sci III 1992 0.80
66 Mutagenicity and cytotoxicity of five antitumor ellipticines in mammalian cells and their structure-activity relationships in Salmonella. Cancer Res 1983 0.80
67 Yeast mitochondrial deoxyribonuclease stimulated by ethidium bromide. 1. Purification and properties. Biochemistry 1979 0.80
68 A new extraction procedure of autonomous DNA from eucaryotic cells, where DNA could be bound to proteins. Nucleic Acids Res 1990 0.79
69 Relationship between cytostatic activity of oxazolopyridocarbazoles and accessibility of DNA intercalation sites in living bacteria. Biochemistry 1986 0.79
70 A new series of ellipticine derivatives (1-(alkylamino)-9-methoxyellipticine). Synthesis, DNA binding, and biological properties. J Med Chem 1988 0.79
71 Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cells. Cancer Res 1986 0.79
72 Ellipticines as potent inhibitors of aryl hydrocarbon hydroxylase: their binding to microsomal cytochromes P450 and protective effect against benzo(a)pyrene mutagenicity. Biochem Pharmacol 1978 0.79
73 Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264--137) in advanced human cancers. Eur J Cancer 1978 0.79
74 Structural changes of polyriboinosinic acid induced by a steroidal diamine, irehdiamine A. Biochem Biophys Res Commun 1967 0.79
75 Cardiovascular activity of 9-hydroxy-ellipticine. Pharmacology 1976 0.78
76 omicron-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate. J Med Chem 1983 0.78
77 Histochemical evidence of altered development of cholinergic fibers in the rat dentate gyrus following lesions. II. Effects of partial entorhinal and simultaneous multiple lesions. J Comp Neurol 1977 0.78
78 Some antitumor derivatives of ellipticine deprived of mutagenic properties. Chem Biol Interact 1978 0.78
79 Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl. Cancer Res 1987 0.78
80 The G.C base-pair preference of 2-N-methyl 9-hydroxyellipticinium. Eur J Biochem 1989 0.78
81 Peroxidase-catalyzed covalent binding of the antitumor drug N2-methyl-9-hydroxyellipticinium to DNA in vitro. Biochemistry 1986 0.78
82 A revised structure of the antitumor drug elliptinium--amino(acid) adducts. Biochem Biophys Res Commun 1985 0.78
83 Lactobacillus rhamnosus GG inhibits invasion of cultured human respiratory cells by prtF1-positive macrolide-resistant group A streptococci. Lett Appl Microbiol 2009 0.78
84 Pattern of recognition of DNA by mammalian DNA topoisomerase II. Biochem Biophys Res Commun 1988 0.78
85 Purification and properties of an acid deoxyribonuclease from the snail Helix aspersa Müll. Biochemistry 1972 0.78
86 Bis(pyrrolecarboxamide) linked to intercalating chromophore oxazolopyridocarbazole (OPC): selective binding to DNA and polynucleotides. Biochemistry 1991 0.78
87 [Hydroxy 9-methyl 2-ellipticinium acetate (NSC 264-137). Toxicologic study and therapeutic effect in 100 cancers (author's transl)]. Nouv Presse Med 1979 0.78
88 A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patients. Cancer Immunol Immunother 1990 0.77
89 Binding of ellipticine base and ellipticinium cation to calf-thymus DNA. A thermodynamic and kinetic study. Eur J Biochem 1988 0.77
90 Stacking and edge-to-edge associations of antitumoral ellipticine derivatives are controlled in solution by interactions involving their nitrogen sites. Biopolymers 1988 0.77
91 Mechanism of cleavage of apurinic sites by 9-aminoellipticine. J Biol Chem 1989 0.77
92 Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L 1210 leukemia. Chem Biol Interact 1979 0.77
93 [Study of displacement reactions between polyribonucleotides by use of ethidium hydrobromate (ETB). Demonstration of displacement of the poly (A-2 I) by poly U]. C R Acad Sci Hebd Seances Acad Sci D 1965 0.77
94 A carboline derivative as a novel mammalian DNA topoisomerase II targeting agent. Biochem Pharmacol 1992 0.76
95 Fasciola hepatica L. homogenate proteolytic activity: action against different substrates. Arch Vet Ital 1969 0.76
96 Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study. Cancer Invest 2006 0.76
97 Regioselective arylation of ribose in adenosine and guanosine with the antitumor drug N2-methyl-9-hydroxyellipticinium acetate. Proc Natl Acad Sci U S A 1984 0.75
98 Peroxidase-catalysed covalent binding of the antitumor drug 2N-methyl-9-hydroxy-ellipticine to proteins. Biochem Pharmacol 1983 0.75
99 Antitumor activity of 9-hydroxyellipticine (NSC 210717) ON L1210 mouse leukemia and the effect of route of injection. Cancer Res 1976 0.75
100 Frameshift mutagenesis in Salmonella typhimurium by reversible DNA intercalators: effect of a UVR B mutation. Biochem Biophys Res Commun 1986 0.75
101 Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites. Cancer Chemother Pharmacol 1985 0.75
102 Effects of 9-hydroxyellipticine on growth and macromolecular synthesis in Escherichia coli. FEBS Lett 1976 0.75
103 Autoxidation of the antitumor drug 9-hydroxyellipticine and its derivatives. J Med Chem 1983 0.75
104 Selective binding of elliptinium acetate onto the 3'-terminal ribose of diribonucleosides monophosphates. Biochem Biophys Res Commun 1985 0.75
105 [2 new antineoplastic derivatives: 9-hydroxy-2-methyl-ellipticinium (acetate) and 9-hydroxy-2,6-dimethyl-ellipticinium (chloride). Effect on mouse L 1210 leukemia]. C R Acad Sci Hebd Seances Acad Sci D 1975 0.75
106 Yeast mitochondrial deoxyribonuclease stimulated by ethidium bromide. 2. Mechanism of enzyme activation. Biochemistry 1979 0.75
107 Rearrangement of mitochondrial DNA molecules during the differentiation of mitochondria in yeast. II. - Labelling studies of the precursor product relationship. Biochimie 1975 0.75
108 [Evaluation of cerebral blood flow in severe brain injuries by SVO2 measurement in the internal jugular vein]. Agressologie 1991 0.75
109 A spectrofluorometric method for the study of transcription of single-stranded DNA by RNA polymerase. Biochim Biophys Acta 1966 0.75
110 Isolation and characterization of the glutathione-elliptinium conjugate in human urine. Anticancer Res 1987 0.75
111 Further observations on the liver fluke (Fasciola hepatica, L.) homogenate capillary permeability activity. Pathol Eur 1969 0.75
112 Heterocyclic Quinones. 4. A new highly cytotoxic drug: 6,7-bis(1-aziridinyl)-5,8-quinazolinedione. J Med Chem 1983 0.75
113 The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence. Acta Eur Fertil 1989 0.75
114 [Clinical tolerance of CY 216 (Fraxiparin) in the prevention of thromboembolic accidents after neurosurgery]. Agressologie 1989 0.75
115 Stimulation by gamma-carboline derivatives (simplified analogues of antitumor ellipticines) of site specific DNA cleavage by calf DNA topoisomerase II. Biochem Pharmacol 1990 0.75
116 Comparison of anti-RNA properties of normal and ellipticine functionalized alpha and beta-oligonucleotides. Nucleic Acids Symp Ser 1991 0.75
117 [The structure of hemoglobins and its functional implications]. Ann Biol Clin (Paris) 1967 0.75
118 [Bipolar disorder: clinical trials with fluoxetine]. Minerva Psichiatr 1993 0.75
119 Ellipticines as potent inhibitors of microsomes-dependent chemical mutagenesis. Chem Biol Interact 1979 0.75
120 Use of a new DNA intercalating fluorescing probe for studies on the mechanism of frameshift mutagenesis in Salmonella typhimurium. Biochimie 1985 0.75
121 [Study of the interaction between a diaminosteroid, Irehdiamine A and transfer RNA]. C R Acad Sci Hebd Seances Acad Sci D 1969 0.75
122 [Fluoxetine and depression in the elderly. Clinical experience]. Minerva Psichiatr 1993 0.75
123 Ellipticine, 9-hydroxyellipticine, and 9-hydroxyellipiticinum: some biochemical properties of possible pharmacologic significance. Cancer Treat Rep 1981 0.75
124 Human and rat urinary metabolites of the antitumor drug Celiptium (N2-methyl-9-hydroxyellipticinium acetate, NSC 264137). Identification of cysteine conjugates supporting the "biooxidative alkylation" hypothesis. Biochem Pharmacol 1983 0.75
125 Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione. J Med Chem 1991 0.75
126 Risk of melanoma following adulthood cancer: a case-control study. Eur J Cancer 2005 0.75
127 [Action of synthetic estrogens on some hematochemical constants in cattle, with special reference to calcium, phosphorus, magnesium and citric acid]. Arch Vet Ital 1969 0.75
128 [In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship]. Bull Cancer 1994 0.75
129 Frameshift mutagenesis in Escherichia coli by reversible DNA intercalators: sequence specificity. Mutat Res 1988 0.75
130 The hydroxylation of the antitumor agent, ellipticine, by liver microsomes from differently pretreated rats. Biochem Pharmacol 1977 0.75
131 Identification of the glucuronide and glutathione conjugates of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate (Celiptium). Comparative disposition of this drug with its olivacinium isomer in rat bile. Drug Metab Dispos 1984 0.75
132 Ethidium bromide mutagenesis in yeast: protection by anaerobiosis. Mutat Res 1975 0.75
133 [Hemodynamic and metabolic effects of thiopental in patients with severe head injuries]. Agressologie 1991 0.75
134 Synergic effect of NADP+ on the antitumor properties of low doses of 9 OH-ellipticine towards Walker cells. Eur J Cancer Clin Oncol 1983 0.75
135 Chemical structure of ethidium bromide metabolites extracted from rat bile. FEBS Lett 1981 0.75
136 [Demonstration of the O-demethylation reaction catalyzed by a peroxidase: application to 9-methoxyellipticine]. C R Acad Sci III 1984 0.75
137 [Evaluation of the efficacy and tolerability of fluoxetine in major depression, Multicenter clinical study]. Minerva Psichiatr 1991 0.75
138 Synthesis and cytotoxic activity of hydroxylated derivatives of olivacine in relation with their biotransformation. J Med Chem 1985 0.75
139 [Behavior of hematological constants in cows with puerperal collapse or "post partum" paresis]. Arch Vet Ital 1971 0.75
140 [Effect of fasting on certain hematochemical constants in cattle, with special reference to calcium, phosphorus, magnesium and citric acid]. Arch Vet Ital 1968 0.75
141 Heterocyclic quinones. XIII. Dimerization in the series of 5,8-quinazolinediones: synthesis and antitumor effects of bis(4-amino-5,8-quinazolinediones). Chem Pharm Bull (Tokyo) 1988 0.75
142 Metabolism of ethidium bromide in rats. Drug Metab Dispos 1981 0.75
143 A graphene oxide pH sensor for wound monitoring. Conf Proc IEEE Eng Med Biol Soc 2016 0.75
144 [Induction of rat hepatic mono-oxygenases by ellipticine: formation of cytochrome p448. Hydroxylating activity]. C R Acad Sci Hebd Seances Acad Sci D 1976 0.75
145 [Existence of duplicative forms of DNA in animal cells]. C R Acad Sci Hebd Seances Acad Sci D 1965 0.75
146 [Value of the multipuncture method in the study of spontaneous or vaccinal tuberculin allergy]. Arch Fr Pediatr 1967 0.75
147 [A study of various smoking cessation programs based on close to 1000 volunteers recruited from the general population: 1-month results]. Rev Epidemiol Sante Publique 1990 0.75
148 Covalent binding of the antitumor agent N2-methyl-9-hydroxy-ellipticinium acetate (NSC 264137) on RNA and poly A in vitro. Biochem Biophys Res Commun 1984 0.75
149 Ulcerative esophagitis during primary HIV infection. Am J Gastroenterol 1992 0.75
150 The hepatic metabolism of ethidium bromide to reactive mutagenic species: biochemical and structural requirements. Biochem Pharmacol 1981 0.75
151 Synthesis, DNA binding, and biological evaluation of synthetic precursors and novel analogues of netropsin. J Med Chem 1989 0.75
152 Structure-activity relationships in the inhibitory effects of ellipticines on benzo(a)pyrene hydroxylase activity and 3-methylcholanthrene mutagenicity. Biochem Pharmacol 1980 0.75
153 [Ethidium bromhydrate effect on L 1210 mouse leukemia]. C R Acad Sci Hebd Seances Acad Sci D 1974 0.75
154 [Efficacy and tolerance of aniracetam in elderly patients with primary or secondary mental deterioration]. Riv Neurol 1992 0.75
155 Metabolism of the anti-tumour drugs N2-methyl-9-hydroxyellipticinium acetate (NSC 264137) and N2-methyl-9-hydroxyolivacinium acetate in the rat: preliminary identification of biliary 9-(O)-glucuronide and 10-(S)-glutathione conjugates. Xenobiotica 1983 0.75
156 Molten carbonate fuel cells fed with biogas: combating H(2)S. Waste Manag 2010 0.75
157 Toxicological and pharmacological studies on 9-hydroxy-ellipticine in mice. Toxicol Appl Pharmacol 1975 0.75
158 Effects of CYP2D6 activity and tobacco on larynx cancer risk. Cancer Epidemiol Biomarkers Prev 1996 0.75
159 Oxidative biotransformation of the antitumour agent elliptinium acetate: Structural characterization of its human and rat urinary metabolites. J Pharm Biomed Anal 1987 0.75
160 [Cardiovascular effect and toxicity of hydroxy-9-ellipticine in dogs]. C R Acad Sci Hebd Seances Acad Sci D 1974 0.75
161 Influence of inducers of monooxygenases on cytotoxic efficiency of ellipticine on leukemia L1210 cells. J Natl Cancer Inst 1981 0.75
162 Metabolism and disposition studies of 9-hydroxyellipticine and 2-methyl-9-hydroxyellipticinium acetate in animals. Cancer Treat Rep 1981 0.75
163 Metabolic transformation of 2-methylellipticinium. Biochem Biophys Res Commun 1980 0.75
164 Studies on the specificity of an acid deoxyribonuclease from Helix aspersa (Müll.). Eur J Biochem 1973 0.75